FindTrial
Sign In

Chances of carrying "Group B streptococcus" and other bacteria in the genito- intestinal tract of pregnant women in Kerala ; and how this can affect the newborn baby- A study

Prevalence of Group B Streptococcus; and profile of microbiota in genito-rectal region of pregnant women in Kerala and relation to Neonatal Outcomes- Prospective Cross-Sectional Study

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/02/023256
Enrollment
1000
Registered
2020-02-11
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: P360- Sepsis of newborn due to streptococcus, group B

Interventions

None listed

Sponsors

Not applicable No sponsor
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All pregnant women booked in KIMS planning to delivery in our institution.

Exclusion criteria

Exclusion criteria: Those who deliver before 36-37 weeks gestation

Design outcomes

Primary

MeasureTime frame
To assess the prevalence of GBS in pregnant women at gestational age between 36-37 weeksTimepoint: To assess the prevalence of GBS in pregnant women at gestational age between 36-37 weeks—

Secondary

MeasureTime frame
- Pattern of Vaginal/ rectal microbiome in pregnant women at gestational age between 36-37 weeks - Effect of maternal Group B Streptococcal Colonization and other microbes on immediate neonatal outcomes Timepoint: - Other microbes detected on vaginal rectal swabs in pregnant women at 36-37 weeks gestation - Neonatal immediate outcomes of screened mothers—

Countries

India

Contacts

Public ContactFemitha Pournami

Kerala Institute of Medical Sciences

femi.shifas@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026